Who We are

We are a highly specialized team of scientists, who find the best way to make regulatory compliance a success. We give small and medium sized biotechs/pharmaceutical companies a fighting chance of getting regulatory approval for their therapies.

Our Vision

Because we believe all companies developing advanced therapies can have great ideas, we guide our clients from the start of their regulatory journey to get their medicines approved and to market quicker so that more people around the world have access to the medicines they need, when they need them, to save lives.

Our Mission

We support advanced therapies companies along their entire product lifecycle by providing affordable, regulatory strategies, that get their products through marketing authorization faster.

Our team

Discover Our Experts

RLM provides regulatory support at all stages of the medicinal product development.

David Louvet
CEO RLM Consulting
Charline Lays
Sr Manager Regulatory Affairs
Marie Genin
Sr Manager Regulatory Affairs
René Mignolet
Founder

Our History

RLM was founded in 2006 by René Mignolet who saw a way to apply his expertise and know-how to actively contribute to the development of new medicines. See the company’s milestones and achievements over the years!

2006

Creation of RLM Consulting

2006
2011

First ODD obtained from FDA

2011
2016

Access granted to Crédit Impôt Recherche enabling a 30% tax deduction on RLM fees for French customers.

2016
2018

RLM assisted over 150 companies

2018
2022

Integration within Univercells Group as a fifth and independent affiliate

2022